What is TMSOF's health score?

THOMSON REUTERS CORP /CAN/ (TMSOF) has a TradeApes health score of 49 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is TMSOF's estimated fair value?

Based on our 5-year discounted cash flow model, THOMSON REUTERS CORP /CAN/'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is TMSOF undervalued or overvalued?

Our model currently rates TMSOF as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for TMSOF... Refresh in a moment for the full analysis.

THOMSON REUTERS CORP /CAN/ (TMSOF)

Communication Services Fair Value High mixed

Updated: 2026-04-21

TradeApes Score

hold

Financial Strength

50 Mixed

Operating Trend

50 Mixed

Relative Value

30 Weak

Capital Allocation

60 Healthy

Risk

70 Healthy

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.